---
title: "鴻盛昌資源：收益約 374.3 百萬港元，同比下降 5.1%"
description: "鴻盛昌資源 8 月 1 日在港交所公告，截至 2025 年 4 月 30 日止年度，鴻盛昌資源集團有限公司及其附屬公司的經營業績如下：收益達到約 374.3 百萬港元，較去年減少約 5.1%；年度溢利約為 0.7 百萬港元，主要由於年內毛利率下降，以及其他收益及虧損減少所致；年度每股基本及攤薄盈利為 0.003 港元。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/251076036.md"
published_at: "2025-07-31T23:32:03.000Z"
---

# 鴻盛昌資源：收益約 374.3 百萬港元，同比下降 5.1%

> 鴻盛昌資源 8 月 1 日在港交所公告，截至 2025 年 4 月 30 日止年度，鴻盛昌資源集團有限公司及其附屬公司的經營業績如下：收益達到約 374.3 百萬港元，較去年減少約 5.1%；年度溢利約為 0.7 百萬港元，主要由於年內毛利率下降，以及其他收益及虧損減少所致；年度每股基本及攤薄盈利為 0.003 港元。

鴻盛昌資源 8 月 1 日在港交所公告，截至 2025 年 4 月 30 日止年度，鴻盛昌資源集團有限公司及其附屬公司的經營業績如下：收益達到約 374.3 百萬港元，較去年減少約 5.1%；年度溢利約為 0.7 百萬港元，主要由於年內毛利率下降，以及其他收益及虧損減少所致；年度每股基本及攤薄盈利為 0.003 港元。

### Related Stocks

- [01850.HK - 鴻盛昌資源](https://longbridge.com/zh-HK/quote/01850.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Standard Chartered PLC (OTCMKTS:SCBFF) Sees Significant Growth in Short Interest | Standard Chartered PLC (OTCMKTS:SCBFF) experienced a significant increase in short interest, rising 21.1% to 210,583 sha | [Link](https://longbridge.com/zh-HK/news/276119010.md) |
| Will China Literature Turn The Page? | China Literature Ltd. expects a net loss of up to 850 million yuan for last year, primarily due to a 1.8 billion yuan go | [Link](https://longbridge.com/zh-HK/news/276113491.md) |
| Huatai Securities Keeps Their Buy Rating on China Literature (CHLLF) | In a report released on February 13, from Huatai Securities maintained a Buy rating on China Literature, with a price ta | [Link](https://longbridge.com/zh-HK/news/275996484.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-HK/news/276035104.md) |
| Tesla's January Sales Drop 17%, But Its Market Share May Have Risen | Tesla's U.S. electric vehicle sales dropped 17% in January, continuing a downward trend exacerbated by the end of the fe | [Link](https://longbridge.com/zh-HK/news/275942023.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。